NewGenIvf Group Limited (NASDAQ:NIVF) Short Interest Down 25.0% in March

NewGenIvf Group Limited (NASDAQ:NIVFGet Free Report) was the recipient of a significant decrease in short interest in the month of March. As of March 31st, there was short interest totalling 142,100 shares, a decrease of 25.0% from the March 15th total of 189,400 shares. Currently, 20.4% of the company’s shares are short sold. Based on an average daily trading volume, of 2,960,000 shares, the days-to-cover ratio is currently 0.0 days.

NewGenIvf Group Price Performance

NIVF traded down $0.07 during midday trading on Friday, reaching $0.28. 1,208,068 shares of the company were exchanged, compared to its average volume of 944,270. The stock’s 50-day simple moving average is $1.18 and its 200 day simple moving average is $7.13. NewGenIvf Group has a one year low of $0.26 and a one year high of $65.60.

Institutional Investors Weigh In On NewGenIvf Group

An institutional investor recently raised its position in NewGenIvf Group stock. XTX Topco Ltd boosted its holdings in shares of NewGenIvf Group Limited (NASDAQ:NIVFFree Report) by 400.6% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 73,801 shares of the company’s stock after acquiring an additional 59,059 shares during the period. XTX Topco Ltd owned approximately 0.73% of NewGenIvf Group worth $30,000 as of its most recent filing with the Securities and Exchange Commission. Institutional investors and hedge funds own 66.24% of the company’s stock.

About NewGenIvf Group

(Get Free Report)

NewGenIVF Group Ltd. operates as an assisted reproductive services provider. It focuses on providing fertility treatments to fulfil the dreams of building families. The firm offers in-vitro fertilization treatment service, comprising traditional IVF and egg donation, and surrogacy and ancillary caring services.

Featured Stories

Receive News & Ratings for NewGenIvf Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NewGenIvf Group and related companies with MarketBeat.com's FREE daily email newsletter.